Efficacy and safety of cisplatin for the management of adult patients with oral cancer A protocol for systematic review

被引：2

作者：

Feng, Yao ^{[1
]}

Yang, Dian-song ^{[1
]}

Tang, Hai-bo ^{[2
]}

Ding, Yuan-sheng ^{[3
]}

Li, Xiao-guang ^{[3
]}

机构：

[1] Jiamusi Univ, Affiliated Hosp 2, Dent Pulp Dis Dept, Unit 1, 566 Changanxi Rd, Jiamusi 154002, Peoples R China

[2] Jiamusi Univ, Affiliated Hosp 2, Dept Radiat, Jiamusi, Peoples R China

[3] Jiamusi Univ, Affiliated Hosp 2, Dept Orthodont, Jiamusi, Peoples R China

来源：

MEDICINE | 2019年 / 98卷 / 51期

关键词：

cisplatin; efficacy; oral cancer; safety; CHEMOTHERAPY; 5-FLUOROURACIL; DOCETAXEL; INFUSION;

D O I：

10.1097/MD.0000000000018210

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Background: Cisplatin is often used for the treatment of oral cancer (OC). However, there are inconsistent results. Thus, this study plans to systematically assess the clinical efficacy and safety of cisplatin for adult patients with OC. Methods: We will search for PUBMED, EMBASE, Cochrane Library, AMED, Cumulative Index to Nursing and Allied Health Literature, Chinese Biomedical Literature Database, and China National Knowledge Infrastructure. All of them will be searched from the construction of each database up to the present with no restrictions of language and publication status. The data analysis will be conducted using RevMan 5.3 software to assess the efficacy and safety of cisplatin for adult patients with OC. Results: This study will summarize the most recent high-quality evidence and will provide helpful information about the efficacy and safety of cisplatin for adult patients with OC. Conclusion: The findings of this study will provide convinced evidence of cisplatin for adult patients with OC, and provide recommendations for clinical practice.

引用

页数：3

共 22 条

[1] 5-Fluorouracil and cisplatin in the treatment of advanced oral cancer [J].

Andreadis, C ;

Vahtsevanos, K ;

Sidiras, T ;

Thomaidis, I ;

Antoniadis, K ;

Mouratidou, D .

ORAL ONCOLOGY, 2003, 39 (04) :380-385

[2]

[Anonymous], 2016, CA-CANCER J CLIN, DOI DOI 10.1007/S40496-016-0081-3

[3]

[Anonymous], 2018, CANC TREAT REV, DOI DOI 10.1016/j.ctrv.2018.03.001

[4] Nanotechnology-based drug delivery systems for treatment of oral cancer: a review [J].

Calixto, Giovana ;

Bernegossi, Jessica ;

Fonseca-Santos, Bruno ;

Chorilli, Marlus .

INTERNATIONAL JOURNAL OF NANOMEDICINE, 2014, 9 :3719-3735

[5] Synergistic inhibitory effects of cetuximab and curcumin on human cisplatin-resistant oral cancer CAR cells through intrinsic apoptotic process [J].

Chen, Chin-Fu ;

Lu, Chi-Cheng ;

Chiang, Jo-Hua ;

Chiu, Hong-Yi ;

Yang, Jai-Sing ;

Lee, Chao-Ying ;

Way, Tzong-Der ;

Huang, Hao-Jen .

ONCOLOGY LETTERS, 2018, 16 (05) :6323-6330

[6] Nanotechnology: a promising method for oral cancer detection and diagnosis [J].

Chen, Xiao-Jie ;

Zhang, Xue-Qiong ;

Liu, Qi ;

Zhang, Jing ;

Zhou, Gang .

JOURNAL OF NANOBIOTECHNOLOGY, 2018, 16

[7] Complete remission in very advanced oral cancer by docetaxel, cisplatin, 5-fluorouracil based induction chemotherapy followed by concurrent chemoradiation [J].

Chiang, Tien-En ;

Ho, Ching-Liang ;

Lin, Chun-Shu ;

Chen, Yuan-Wu .

JOURNAL OF DENTAL SCIENCES, 2018, 13 (01) :82-84

[8] The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed [J].

Deeks, JJ ;

Macaskill, P ;

Irwig, L .

JOURNAL OF CLINICAL EPIDEMIOLOGY, 2005, 58 (09) :882-893

[9] Late stage diagnosis of oral cancer: Components and possible solutions [J].

Guneri, Pelin ;

Epstein, Joel B. .

ORAL ONCOLOGY, 2014, 50 (12) :1131-1136

[10] Changing Trends in oral cancer - a global scenario [J].

Gupta, Neha ;

Gupta, Ritu ;

Acharya, Arun Kumar ;

Patthi, Basavaraj ;

Goud, Venkatesh ;

Reddy, Somanath ;

Garg, Anshul ;

Singla, Ashish .

NEPAL JOURNAL OF EPIDEMIOLOGY, 2016, 6 (04) :613-619

← 1 2 3 →